Expression analysis of TCGA samples
Basic Information
VIS ID
TVIS10001653
Fusion event
HBV-P4HB integration
Validated
No
Detection method
HIVID
Data source
Curated
Sample type
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Reported year
2016
PubMed ID
Virus Sequence
Virus name
HBV
Reference genome
AF090842.1;AB033554.1;AB014381.1;M32138.1;AB032431.1;AB036910.1;AB064310;AY090454.1
Host Sequence
Chromosome
chr17
Cytoband
q25.3
Reference genome
Start
End
79817302/81859426 (Hg38)
Location type
Intronic
Target gene
miRNAs that regulate target gene
hsa-mir-210-3p ; hsa-mir-615-3p ; hsa-mir-18a-3p ; hsa-mir-484 ; hsa-mir-183-5p ; hsa-mir-92a-3p ; hsa-mir-188-5p ; hsa-mir-3672 ; hsa-mir-4520-3p ; hsa-mir-6516-3p ; hsa-mir-422a ; hsa-mir-378i ; hsa-mir-378h ; hsa-mir-378f ; hsa-mir-378e ; hsa-mir-378d ; hsa-mir-378c ; hsa-mir-378b ; hsa-mir-378a-3p ; hsa-mir-4638-3p ; hsa-mir-518c-5p ; hsa-mir-451b ; hsa-mir-514a-5p ; hsa-mir-548n ; hsa-mir-1252-5p ; hsa-mir-1294 ; hsa-mir-135b-3p ; hsa-mir-298 ; hsa-mir-3650 ; hsa-mir-3919 ; hsa-mir-4292 ; hsa-mir-4308 ; hsa-mir-4710 ; hsa-mir-4756-3p ; hsa-mir-4787-5p ; hsa-mir-483-5p ; hsa-mir-548e-5p ; hsa-mir-597-5p ; hsa-mir-6077 ; hsa-mir-6134 ; hsa-mir-642b-5p ; hsa-mir-668-3p ; hsa-mir-670-5p ; hsa-mir-6752-5p ; hsa-mir-6758-5p ; hsa-mir-6782-5p ; hsa-mir-6791-5p ; hsa-mir-6842-5p ; hsa-mir-6856-5p ; hsa-mir-7110-5p ; hsa-mir-7854-3p ; hsa-mir-887-3p
Nearest miRNA
hsa-mir-10226/Upstream/165557; hsa-mir-4525/Downstream/377242;
Nearest CpG islands
None/Target, chr17-CpG: 26/Upstream/12814, chr17-CpG: 147/Downstream/567
Upstream sequence
TTCCCAGCGGCTTTGGCATACTCAGGGGCCAGAGCCTTGCAGTGGCCACACCAAGGGGCATCTGGAAGCGGAAATGAGATGCTAGAAAGCAGCCTTGATC
Downstream sequence
CCTAAAGCAGCCTTGATCCCTCAGCAGTGCTTCCCTTTTTCCTCTGGCATTTCCCTTCATAAAAACCTTATCTACTCACCAAGATAACCCCTCCTAACGC
Reference
Zhao, L. H., et al.Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma. Nat Commun ,2016,7: 12992.